A. Hedayat

Also affiliated with Melanoma Institute Australia, Quest Diagnostics (United States)

EngineeringPhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapy”.

Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapy

Frontiers in Oncology(2025)10.3389/fonc.2025.1500785

N/A

0DataRank · unranked

0 citations

Wolfram E. Samlowski, Brandon Reynolds, A. Hedayat, Chalette Lambert-Swainston

PD-1 monoclonal antibodies as an effective treatment for rare cutaneous malignancies: a case report

Frontiers in Oncology(2025)10.3389/fonc.2025.1609767

N/A

0DataRank · unranked

0 citations

Wolfram E. Samlowski, A. Hedayat, Ryan Falk